All Articles

Tennessee Oncology's new Tullahoma center isn't just a building. It's a calculated move in the decentralization of advanced medicine, a model reshaping patient care and regional economies.

With the hire of practitioner-turned-executive Diana Dennett, CLEARSTEM isn't just scaling. It's betting its future on a new C-suite archetype.

SHEIN's new kids' collection with influencer Cheyenne Davis showcases a savvy marketing strategy, but can philanthropy and affordability outweigh fast fashion's ethical cost?

With $100M in total funding, bioinformatics firm Inocras plans to challenge U.S. precision oncology leaders by leveraging its whole-genome sequencing success in Asia.

As Sonida Senior Living prepares its Q2 results, investors are watching closely. Can the operator prove its massive merger is paying off amidst industry-wide cost pressures?

As AI agents proliferate, a new class of threats emerges. The Cloud Security Alliance, with Rubrik, is launching a new center to build enterprise resilience.

How a boutique airline used a historic baseball moment to cement its brand in L.A., celebrating Taiwanese pride and redefining corporate sponsorship.

As mainframes face a talent crisis, Izzi Software's Z/XDC debugger on VS Code aims to attract new developers. Is this the key to securing vital legacy systems?

A pivotal CMS ruling grants Carlsmed's AI-driven spinal implants a dedicated payment code, unlocking market access and signaling a new era for med-tech.

The Oncology Institute's transformation into Starling Oncology signals a strategic pivot to solve the cancer cost crisis through a tech-enabled, coordinated model.

Powerus just landed a major Air Force contract, but the real story is its pending merger with a golf course operator. We dissect the risks and rewards of this unorthodox deal.

The nationwide launch of Ritual's prenatal vitamin at Costco is more than a distribution win; it's a stress test for a new retail model based on clinical proof.

As legacy data protection fails in the AI era, ORION Security's rapid growth signals a market shift. Is their 'agentic' AI the answer to alert fatigue?

With the appointment of Ph.D. holder and patent inventor Bruce Christensen as CEO, FORTA signals a strategic shift towards accelerated, tech-driven growth.

Cohen & Company's Q2 results showcase its mastery of the resurgent SPAC market. With revenue soaring to $69.5M and major deals inked, the boutique firm proves that specialized expertise can deliver outsized returns.

McNally Capital's majority stake in TENICA signals a strategic shift, with private equity now a key player in funding America's next-gen cyber and space defense.

Amidst the fallout of its CEO's ouster, Anavex Life Sciences unveils a new board slate to fend off an activist investor's bid for total control.

As global baby gear giant Joie enters Canada, it's not just about strollers. It's a test of retail strategy, a challenge to safety standards, and a bold move in a multi-billion dollar market.

Guidewire's new Qusar release introduces an 'Agentic Framework,' moving AI from isolated experiments to the core of P&C operations. Is this the key to durable value?

Faced with impossible costs and AI anxiety, Gen Z and Millennials are delaying the American Dream. But they aren't giving up—they're rewriting the rules.